<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02290704</url>
  </required_header>
  <id_info>
    <org_study_id>2013MEKY039</org_study_id>
    <nct_id>NCT02290704</nct_id>
  </id_info>
  <brief_title>Retinal Oxygen Saturation in Patients With Graves' Ophthalmopathy and in Normal People</brief_title>
  <official_title>Changes of Retinal Oxygen Saturation in Patients With Graves' Ophthalmopathy Under Different Managing Conditions and in Normal People</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sun Yat-sen University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sun Yat-sen University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Find if the retinal function is affected in both the nonsevere and the severe stage of
      Graves' ophthalmopathy (GO) by comparing the retinal oxygen saturation of GO patients with
      that of normal people.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Graves'ophthalmopathy (GO), also called thyroid-associated ophthalmopathy, is often mild and
      self-limiting, and probably declining in frequency, with only 3-5% of cases posing a threat
      to eyesight, remaining a pathogenetic enigma and a therapeutic dilemma. In its nonsevere
      expression, the symptoms and signs include Photophobia, Foreign body sensation, Eyelid
      retraction, increased intraocular pressure, Lagophthalmos, and Mild diplopia. In its severe
      expression, it is a disfiguring and invalidating disease with the optic nerve damaged.
      However, in this study, we want to find if the retinal vessels is affected in the early stage
      of the disease through observing the oxygen saturation of the retinal vessels and compare it
      with that of the normal people.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2014</start_date>
  <completion_date type="Anticipated">November 2017</completion_date>
  <primary_completion_date type="Actual">November 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>changes of retinal oxygen saturation in patients with GO under different managing conditions</measure>
    <time_frame>before surgery ( or glucocorticoids administration), 1 week and 4 weeks after surgery ( or glucocorticoids administration)</time_frame>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Graves' Ophthalmopathy</condition>
  <arm_group>
    <arm_group_label>controls</arm_group_label>
    <description>People without eye disease</description>
  </arm_group>
  <arm_group>
    <arm_group_label>GO patients</arm_group_label>
    <description>patients with Graves' ophthalmopathy</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Controls- normal people; GO patients- patients with Graves' ophthalmopathy
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria for GO patients:

          1. conforms to the diagnosis of Graves' ophthalmopathy;

          2. age &gt; 18;

          3. volunteered to participate in this research, and sign the informed consent.

        Inclusion Criteria for Control group:

          1. age &gt; 18;

          2. diopter within + / - 3D;

          3. volunteered to participate in this research, and sign the informed consent.

        Exclusion Criteria for GO patients:

          1. Fundus could not be seen clearly;

          2. pregnant and lactating women;

          3. could not tolerate the examination.

        Exclusion Criteria for Control group:

          1. with severe systemic disease and cause eye lesions;

          2. have history of eye disease, ocular trauma and eye surgery impacting on visual
             function;

          3. pregnant and lactating women;

          4. could not tolerate the examination.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Danping Huang</last_name>
    <role>Study Chair</role>
    <affiliation>Zhongshan Ophthalmic Center, Sun Yat-sen University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Xiaonan Yang</last_name>
    <role>Study Director</role>
    <affiliation>Zhongshan Ophthalmic Center, Sun Yat-sen University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Siming Ai</last_name>
    <role>Principal Investigator</role>
    <affiliation>Zhongshan Ophthalmic Center, Sun Yat-sen University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Huasheng Yang</last_name>
    <role>Principal Investigator</role>
    <affiliation>Zhongshan Ophthalmic Center, Sun Yat-sen University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Danping Huang</last_name>
    <phone>+8613501508328</phone>
    <email>hdanp@mail.sysu.edu.cn</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Xiaonan Yang</last_name>
    <phone>+8613751859797</phone>
    <email>yangxn3@mail2.sysu.edu.cn</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Zhongshan Ophthalmic Center</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xiaonan Yang, Master</last_name>
      <phone>+8613751859797</phone>
      <email>yangxn3@mail2.sysu.edu.cn</email>
    </contact>
    <contact_backup>
      <last_name>Danping Huang, Docter</last_name>
      <phone>+8613501508328</phone>
      <email>hdanp@mail.sysu.edu.cn</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Bahn RS, Heufelder AE. Pathogenesis of Graves' ophthalmopathy. N Engl J Med. 1993 Nov 11;329(20):1468-75. Review.</citation>
    <PMID>8413459</PMID>
  </reference>
  <reference>
    <citation>Alford EL, Soparkar CN. Management of the 'tight orbit' and associated visual loss. Curr Opin Otolaryngol Head Neck Surg. 2013 Aug;21(4):417-22. doi: 10.1097/MOO.0b013e32836312a1. Review.</citation>
    <PMID>23838551</PMID>
  </reference>
  <results_reference>
    <citation>Michelson G, Scibor M. Intravascular oxygen saturation in retinal vessels in normal subjects and open-angle glaucoma subjects. Acta Ophthalmol Scand. 2006 Jun;84(3):289-95.</citation>
    <PMID>16704685</PMID>
  </results_reference>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 3, 2014</study_first_submitted>
  <study_first_submitted_qc>November 13, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 14, 2014</study_first_posted>
  <last_update_submitted>November 25, 2017</last_update_submitted>
  <last_update_submitted_qc>November 25, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 28, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sun Yat-sen University</investigator_affiliation>
    <investigator_full_name>Xiaonan Yang</investigator_full_name>
    <investigator_title>the graduate student of Zhongshan Ophthalmic Center</investigator_title>
  </responsible_party>
  <keyword>oxygen saturation</keyword>
  <keyword>retinal vessels</keyword>
  <keyword>thyroid associated ophthalmopathy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Eye Diseases</mesh_term>
    <mesh_term>Graves Ophthalmopathy</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

